Pyoderma gangrenosum with plasma cell dyscrasia should be subject for anti-myeloma treatment
Hareth Nahi1,2, Gabriel Afram1,2, Hanna Brauner3,4
1Center for Hematology and Regenerative Medicine, Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.
International Journal of Dermatology
|March 22, 2021
Abstract
No abstract available in PubMed .
More Related Videos
08:17A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research
Published on: August 15, 2019
14.9K
06:39Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
9.9K
